Cellular therapy for childhood neurodegenerative disease. Part II: clinical trial design and implementation.

Abstract

Cellular replacement therapy attempts to improve functioning of the diseased human central nervous system (CNS). In this second installment of a 2-part review, the authors discuss the major challenges to the translation of in vitro and animal studies of neural stem cell (NSC) therapy in the clinical setting. This analysis details the problems unique to the… (More)
DOI: 10.3171/FOC/2008/24/3-4/E22

Topics

Cite this paper

@article{Selden2008CellularTF, title={Cellular therapy for childhood neurodegenerative disease. Part II: clinical trial design and implementation.}, author={Nathan Richard Selden and D. Guillaume and Robert D. Steiner and Stephen L. Huhn}, journal={Neurosurgical focus}, year={2008}, volume={24 3-4}, pages={E23} }